- Home
- KIM vs HOLX Comparison
KIM vs HOLX Comparison
Compare KIM & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KIM | HOLX |
|---|---|---|
| Founded | 1958 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical Electronics |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.1B | 16.6B |
| IPO Year | 1991 | 1990 |
Fundamental Metrics
Financial Performance| Metric | KIM | HOLX |
|---|---|---|
| Price | $20.43 | $74.97 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 12 | 15 |
| Target Price | $24.17 | ★ $79.64 |
| AVG Volume (30 Days) | ★ 4.8M | 2.9M |
| Earning Date | 10-30-2025 | 02-04-2026 |
| Dividend Yield | ★ 5.09% | N/A |
| EPS Growth | ★ 57.13 | N/A |
| EPS | 0.83 | ★ 2.49 |
| Revenue | $2,123,057,000.00 | ★ $4,100,500,000.00 |
| Revenue This Year | $5.64 | $6.69 |
| Revenue Next Year | $3.02 | $5.74 |
| P/E Ratio | ★ $24.59 | $30.09 |
| Revenue Growth | ★ 8.14 | 1.74 |
| 52 Week Low | $17.93 | $51.90 |
| 52 Week High | $24.62 | $75.34 |
Technical Indicators
Market Signals| Indicator | KIM | HOLX |
|---|---|---|
| Relative Strength Index (RSI) | 50.51 | 63.90 |
| Support Level | $20.05 | $74.91 |
| Resistance Level | $20.59 | $75.19 |
| Average True Range (ATR) | 0.30 | 0.26 |
| MACD | 0.06 | -0.11 |
| Stochastic Oscillator | 71.47 | 54.43 |
Price Performance
Historical ComparisonAbout KIM Kimco Realty Corporation (HC)
One of the oldest real estate investment trusts in the United States, Kimco Realty owns interests in 567 shopping centers throughout major markets in the US, representing roughly 101 million square feet.
About HOLX Hologic Inc.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.